Estimation of successful capping with complete aspiration of bladder via nephroureterostomy tube

Table 1 Patient demographics and capping trial outcomes

	Total	Successful capping	Unsuccessful capping
NUT procedures	37	30 (81%), 95%CI: 0.65-0.92	7 (19%), 95%CI: 0.80-0.35
Patients	34
Gender
Male	19	17	2
Female	15	10	5
Age (yr)
Average (range)	58 (2-83)	59 (2-83)	56 (24-73)
Underlying cancer (procedures)
	Prostate: 9	Prostate: 7	Prostate: 2
	Bladder: 5	Bladder: 5
	Colorectal: 5	Colorectal: 5
	Endometrial: 5	Endometrial: 3	Endometrial: 2
	Breast: 2	Breast: 1	Breast: 1
	Cervical: 2	Cervical: 2
	Gastric: 2	Gastric: 1	Gastric: 1
	Neuroblastoma: 2	Neuroblastoma: 2
	Ovarian: 1	Ovarian: 1
	Renal: 1	Renal: 1
	Sarcoma: 1	Sarcoma: 1
	Testicular: 1	Testicular: 1
	Crohn’s: 1		Crohn’s: 1
Catheter size (French)
8.5	14	11	3
10	23	19	4
Catheter length (cm)
22	10	8	2
24	16	13	3
26	8	6	2
28	2	2	0
32	1	1	0
Side
Right	18	16	2
Left	10	6	4
Bilateral	4	3	1
Capping length (d)
Average, Median, Range		40, 24.5, 12-94	12, 10, 2-22
Outcomes		Conversion to internal stent (n = 23); Routine exchange (n = 5); Removal (n = 1); Unrelated death (n = 1)	Peri catheter leakage (n = 3); Elevated creatinine (n = 2); Fever/hematuria (n = 1); Nausea/vomiting (n = 1)

NUT: Nephroureterostomy tube.